Invention Grant
- Patent Title: Carboline carboxamide compounds useful as kinase inhibitors
- Patent Title (中): 用作激酶抑制剂的卡泊芬羧酰胺化合物
-
Application No.: US13704297Application Date: 2011-06-16
-
Publication No.: US08685969B2Publication Date: 2014-04-01
- Inventor: Chunjian Liu , James Lin , George V. DeLucca , Douglas G. Batt , Qingjie Liu
- Applicant: Chunjian Liu , James Lin , George V. DeLucca , Douglas G. Batt , Qingjie Liu
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu; Mark K. VanAtten; Gary D. Greenblatt
- International Application: PCT/US2011/040615 WO 20110616
- International Announcement: WO2011/159857 WO 20111222
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04
Abstract:
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, formula (I) are useful as kinase modulators, including Btk modulation.
Public/Granted literature
- US20130096118A1 CARBOLINE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2013-04-18
Information query
